Ectica Technologies supplies hydrogel-based tools to the biopharmaceutical and life science industries for drug discovery and bioresearch applications. The company’s patented 3DProSeed™ technology combines the biological relevance of hydrogel-based cultures with high workflow integration levels in drug discovery.
3DProSeed is a microtitre plate containing a pre-assembled, fully synthetic hydrogel that is delivered to the customer’s hydrated, ready-for-cell seeding.
We supply the 3DProSeed product line for drug discovery and research in oncology, immuno-oncology and neurosciences. Ectica Technologies also engages in contract development and production of customised solutions in terms of hydrogel chemistry, product format, usage and branding.
Zurich, Zurich 8045 Switzerland